LGALS9 and autoimmune disease: Additionally, inducing regulatory phenotypes in fibroblasts by stimulating the expression of molecules such as Gal-9 or Fas/FasL offers a novel approach for suppressing aberrant immune responses in autoimmune diseases 116.